Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06585592
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-29
Brief Title:
Establishment of Multimodal-multiparametric Progressive Prediction Models for Thyroid Associated Ophthalmopathy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Establishment of Multimodal-multiparametric Progressive Prediction Models for Thyroid Associated Ophthalmopathy
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Thyroid-associated ophthalmopathy TAO is an organ-specific autoimmune disease closely related to thyroid disease which leads the incidence of orbital disease in adults and is the most common cause of diffuse toxic goiter Graves disease GD The clinical manifestations of TAO are complex and varied In severe cases it may seriously impair visual function affect daily life and even cause corneal ulceration perforation and blindness Therefore a reasonable and effective treatment plan should be chosen according to the degree of TAO
The aim of this clinical study is to
1 Found characteristic changes from baseline to the end of treatment
2 Identify characteristic changes associated with treatment response
3 Construct a multimodal and multiparameter prediction model by characteristic changes
The aim of this clinical study is to
1 Found characteristic changes from baseline to the end of treatment
2 Identify characteristic changes associated with treatment response
3 Construct a multimodal and multiparameter prediction model by characteristic changes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None